SCHEMBL28244458

SCHEMBL28244458

O=C(NCCl)c1ccccn1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.65
SMN1; SMN2 Q16637 2/20 0.65
EPHX2 P34913 1/20 0.59
MEN1 O00255 4/20 0.58
HTT P42858 2/20 0.58
ALDH1A1 P00352 1/20 0.56
CES2 O00748 1/20 0.55
CES1 P23141 1/20 0.55
HDAC3 O15379 1/20 0.55
HDAC4 P56524 1/20 0.55
HDAC1 Q13547 1/20 0.55
HDAC7 Q8WUI4 1/20 0.55
HDAC2 Q92769 1/20 0.55
HDAC10 Q969S8 1/20 0.55
HDAC11 Q96DB2 1/20 0.55
HDAC8 Q9BY41 1/20 0.55
HDAC6 Q9UBN7 1/20 0.55
HDAC9 Q9UKV0 1/20 0.55
HDAC5 Q9UQL6 1/20 0.55
TSHR P16473 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31658991 0.86 KMT2A (0.83) KMT2ASMN1; SMN2EPHX2MEN1ALDH1A1
SCHEMBL9341104 0.86 KMT2A (0.83) KMT2ASMN1; SMN2EPHX2MEN1ALDH1A1
SCHEMBL11721101 0.85 KMT2A (0.71) KMT2ASMN1; SMN2EPHX2MEN1ALDH1A1
SCHEMBL1503134 0.85 KMT2A (0.65) KMT2ASMN1; SMN2EPHX2MEN1HTT
Hydrochloric Acid SCHEMBL11716759 0.84 KMT2A (0.69) KMT2ASMN1; SMN2EPHX2MEN1ALDH1A1
SCHEMBL8516755 0.83 SMN1; SMN2 (0.90) KMT2ASMN1; SMN2EPHX2MEN1ALDH1A1
SCHEMBL2516053 0.83 KDM4E (0.69) KMT2ASMN1; SMN2EPHX2MEN1HTT
SCHEMBL16215618 0.83 KMT2A (0.63) KMT2ASMN1; SMN2EPHX2MEN1HTT
SCHEMBL509641 0.83 KMT2A (0.63) KMT2ASMN1; SMN2EPHX2MEN1HTT
SCHEMBL3673650 0.83 KMT2A (0.73) KMT2ASMN1; SMN2EPHX2MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105646341-B sorafenib compound 杭州华东医药集团新药研究院有限公司 2018-10-16 CN claimed
CN-110229099-A A method of preparing Sorafenib key intermediate 连云港恒运药业有限公司 2019-09-13 CN disclosed
CN-105399668-B A kind of method that \" one kettle way \" prepares Sorafenib 开封制药(集团)有限公司 2018-11-16 CN disclosed